Arjun Sarker - Avanos Medical Senior Vice President - International
| 8HH Stock | EUR 17.60 0.20 1.15% |
President
Mr. Arjun Ranjan Sarker is Senior Vice President International of the Company. Mr. Sarker joined the Company in January 2017 as Vice President and General Manager of the Companys AsiaPacific business. Prior to joining the Company, from 2007 to 2017, he held various leadership roles in general management and finance at MedtronicCovidien. Prior to that, he worked at Honeywell in its specialty materials portfolio, at a British distribution group and at a public accounting firm. He is a former member of the advisory board of CFO Asia magazine, a regular panelist at Economist CFO roundtables and was cochairman of the Medical Devices committee in AMCHAM India. since 2018.
| Age | 57 |
| Tenure | 6 years |
| Phone | 844 428 2667 |
| Web | https://avanos.com |
Arjun Sarker Latest Insider Activity
Tracking and analyzing the buying and selling activities of Arjun Sarker against Avanos Medical stock is an integral part of due diligence when investing in Avanos Medical. Arjun Sarker insider activity provides valuable insight into whether Avanos Medical is net buyers or sellers over its current business cycle. Note, Avanos Medical insiders must abide by specific rules, including filing SEC forms every time they buy or sell Avanos Medical'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Arjun Sarker over three months ago Acquisition by Arjun Sarker of 6058 shares of Avanos Medical subject to Rule 16b-3 | ||
Arjun Sarker over a year ago Acquisition by Arjun Sarker of 4562 shares of Avanos Medical subject to Rule 16b-3 | ||
Arjun Sarker over a year ago Acquisition by Arjun Sarker of 6058 shares of Avanos Medical subject to Rule 16b-3 |
Avanos Medical Management Efficiency
The company has return on total asset (ROA) of 0.0236 % which means that it generated a profit of $0.0236 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0348 %, meaning that it generated $0.0348 on every $100 dollars invested by stockholders. Avanos Medical's management efficiency ratios could be used to measure how well Avanos Medical manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 1 records | PRESIDENT Age | ||
| Hamish Greig | Lion One Metals | N/A | |
Management Performance
| Return On Equity | 0.0348 | |||
| Return On Asset | 0.0236 |
Avanos Medical Leadership Team
Elected by the shareholders, the Avanos Medical's board of directors comprises two types of representatives: Avanos Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Avanos. The board's role is to monitor Avanos Medical's management team and ensure that shareholders' interests are well served. Avanos Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Avanos Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Michelle Scharfenberg, VP Officer | ||
| Michael Greiner, CFO VP | ||
| Scott Galovan, VP Devel | ||
| David Crawford, VP Treasurer | ||
| Arjun Sarker, Senior Vice President - International | ||
| David Ball, Senior Vice President - Global Supply Chain & Procurement | ||
| William Haydon, VP Management | ||
| Kerr Holbrook, VP Care | ||
| Joseph Woody, CEO, Director | ||
| Mojirade James, Gen VP |
Avanos Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Avanos Medical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0348 | |||
| Return On Asset | 0.0236 | |||
| Profit Margin | 0.06 % | |||
| Operating Margin | 0.08 % | |||
| Current Valuation | 1.35 B | |||
| Shares Outstanding | 46.5 M | |||
| Shares Owned By Insiders | 1.65 % | |||
| Shares Owned By Institutions | 95.00 % | |||
| Price To Earning | 108.36 X | |||
| Price To Book | 0.97 X |
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in Avanos Stock
When determining whether Avanos Medical is a strong investment it is important to analyze Avanos Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Avanos Medical's future performance. For an informed investment choice regarding Avanos Stock, refer to the following important reports:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Avanos Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For more detail on how to invest in Avanos Stock please use our How to Invest in Avanos Medical guide.You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..